SCHEMBL10165313

SCHEMBL10165313

Cc1ncc(-c2ccc(F)cc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
ACHE P22303 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
FYN P06241 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
TDO2 P48775 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12786339 0.87 NPC1 (0.44) PDGFRBPDGFRAHDAC3HDAC4HDAC7
SCHEMBL10000246 0.80 NPSR1 (0.48) PDGFRBPDGFRAACHEHDAC6MEN1
SCHEMBL10000245 0.80 NPSR1 (0.48) PDGFRBPDGFRAACHEHDAC6MEN1
SCHEMBL26951228 0.79 CYP2A6 (0.52) HDAC3HDAC4HDAC7HDAC8HDAC6
SCHEMBL2757257 0.79 TDO2 (0.51) PDGFRBPDGFRAACHENPC1RAB9A
SCHEMBL10021910 0.79 NPC1 (0.35) HDAC3HDAC4HDAC7HDAC8HDAC6
SCHEMBL17055533 0.78 RAB9A (0.58) HDAC3HDAC4HDAC7HDAC8HDAC6
SCHEMBL13310775 0.77 NISCH (0.44) PDGFRBPDGFRAHDAC3HDAC4HDAC7
SCHEMBL2757262 0.76 NPSR1 (0.55) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL1951940 0.76 MAPT (0.52) MEN1KMT2AFYNNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716289-B2 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-05-06 US disclosed
US-8716289-B2 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-05-06 US disclosed
US-20120015950-A1 CARBAMATE DERIVATIVES OF ALKYL-HETEROCYCLES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015950-A1 CARBAMATE DERIVATIVES OF ALKYL-HETEROCYCLES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF INTS9, CDK8, SCN8A PDGFRB 2634/4885PDGFRA 2344/4885ACHE 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.